Cause of death in patients with atrial fibrillation admitted to French hospitals in 2012: a nationwide database study

被引:46
作者
Fauchier, Laurent [1 ,2 ,3 ,4 ]
Samson, Adeline [5 ]
Chaize, Gwendoline [6 ]
Gaudin, Anne-Francoise [7 ]
Vainchtock, Alexandre [6 ]
Bailly, Cecile [7 ]
Cotte, Francois-Emery [7 ]
机构
[1] CHU Trousseau, Serv Cardiol, Tours, France
[2] CHU Trousseau, Lab Electrophysiol Cardiaque, Pole Coeur Thorax, Tours, France
[3] CHU Trousseau, Asculaire, Tours, France
[4] Univ Tours, Fac Med, Tours, France
[5] Paris Dauphine Univ, Paris, France
[6] HEVA, Lyon, France
[7] Bristol Myers Squibb, Rueil Malmaison, France
关键词
D O I
10.1136/openhrt-2015-000290
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: Most patients with atrial fibrillation (AF) have risk factors and coexisting conditions that increase their mortality risk. We performed a cause-of-death analysis to identify predictors of mortality in hospitalised patients with AF in France. Methods and results: In this retrospective, population-based cross-sectional study, the Programme de medicalisation des systemes d'information was used to identify 533 044 adults with a diagnosis of AF or atrial flutter hospitalised for any reason in France from January through December 2012. Stepwise multivariable analyses were performed to identify determinants of mortality. The mean age was 78.0 +/- 11.4 years, 47.1% were women, and the mean CHA(2)DS(2)-VASc score was 4.0 +/- 1.8. During hospitalisation, 9.4% (n=50 165) of the patients died, 34% due to a cardiovascular event, most often heart failure (16.6%), stroke/transient ischaemic attack/systemic embolism (9.8%) or vascular or ischaemic disease (4.0%). The strongest predictors of overall death were age >= 75 years (OR 2.57, 95% CI 2.47 to 2.68), renal failure (OR 1.85, 95% CI 1.81 to 1.89), cancer (OR 1.81, 95% CI 1.78 to 1.85) and lung disease (OR 1.58, 95% CI 1.55 to 1.62). Conclusions: Cardiovascular events were the most common cause of death, occurring in one-third of patients, in this comprehensive study of hospitalised patients with AF. Despite the high risk of stroke in this population, only 10% died from stroke/transient ischaemic attack/systemic embolism. The strongest predictors of overall death were non-cardiovascular. Physicians should be encouraged to focus on preventable serious and disabling cardiovascular events (such as stroke) as well as on potentially fatal non-cardiovascular comorbidities.
引用
收藏
页数:10
相关论文
共 35 条
[1]  
Aouba A, 2011, BEH, V22, P249
[2]   Impact of atrial fibrillation on the risk of death [J].
Benjamin, EJ ;
Wolf, PA ;
D'Agostino, RB ;
Silbershatz, H ;
Kannel, WB ;
Levy, D .
CIRCULATION, 1998, 98 (10) :946-952
[3]  
Camm AJ, 2010, EUR HEART J, V31, P2369, DOI [10.1093/eurheartj/ehq278, 10.1093/europace/euq350]
[4]   Hospital discharge data can be used for monitoring procedures and intensive care related to severe maternal morbidity [J].
Chantry, Anne A. ;
Deneux-Tharaux, Catherine ;
Cans, Christine ;
Ego, Anne ;
Quantin, Catherine ;
Bouvier-Colle, Marie-Helene .
JOURNAL OF CLINICAL EPIDEMIOLOGY, 2011, 64 (09) :1014-1022
[5]   Epidemiology of atrial fibrillation in France: Extrapolation of international epidemiological data to France and analysis of French hospitalization data [J].
Charlemagne, Agnes ;
Blacher, Jacques ;
Cohen, Ariel ;
Collet, Jean-Philippe ;
Dievart, Francois ;
de Groote, Pascal ;
Hanon, Olivier ;
Leenhardt, Antoine ;
Pinel, Jean-Francois ;
Pisica-Donose, George ;
Le Heuzey, Jean-Yves .
ARCHIVES OF CARDIOVASCULAR DISEASES, 2011, 104 (02) :115-124
[6]   Cost of stroke in France [J].
Chevreul, K. ;
Durand-Zaleski, I. ;
Gouepo, A. ;
Fery-Lemonnier, E. ;
Hommel, M. ;
Woimant, F. .
EUROPEAN JOURNAL OF NEUROLOGY, 2013, 20 (07) :1094-1100
[7]   Characteristics and management of outpatients with history of or current atrial fibrillation: The observational French EPHA study [J].
Cohen, Ariel ;
Dallongeville, Jean ;
Durand-Zaleski, Isabelle ;
Bouee, Stephane ;
Le Heuzey, Jean-Yves .
ARCHIVES OF CARDIOVASCULAR DISEASES, 2010, 103 (6-7) :376-387
[8]   Risk of Death and Cardiovascular Events in Initially Healthy Women With New-Onset Atrial Fibrillation [J].
Conen, David ;
Chae, Claudia U. ;
Glynn, Robert J. ;
Tedrow, Usha B. ;
Everett, Brendan M. ;
Buring, Julie E. ;
Albert, Christine M. .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2011, 305 (20) :2080-2087
[9]   Apixaban in Patients with Atrial Fibrillation [J].
Connolly, Stuart J. ;
Eikelboom, John ;
Joyner, Campbell ;
Diener, Hans-Christoph ;
Hart, Robert ;
Golitsyn, Sergey ;
Flaker, Greg ;
Avezum, Alvaro ;
Hohnloser, Stefan H. ;
Diaz, Rafael ;
Talajic, Mario ;
Zhu, Jun ;
Pais, Prem ;
Budaj, Andrzej ;
Parkhomenko, Alexander ;
Jansky, Petr ;
Commerford, Patrick ;
Tan, Ru San ;
Sim, Kui-Hian ;
Lewis, Basil S. ;
Van Mieghem, Walter ;
Lip, Gregory Y. H. ;
Kim, Jae Hyung ;
Lanas-Zanetti, Fernando ;
Gonzalez-Hermosillo, Antonio ;
Dans, Antonio L. ;
Munawar, Muhammad ;
O'Donnell, Martin ;
Lawrence, John ;
Lewis, Gayle ;
Afzal, Rizwan ;
Yusuf, Salim .
NEW ENGLAND JOURNAL OF MEDICINE, 2011, 364 (09) :806-817
[10]   Incidence and Cost of Stroke and Hemorrhage in Patients Diagnosed with Atrial Fibrillation in France [J].
Cotte, Francois-Emery ;
Chaize, Gwendoline ;
Kachaner, Isabelle ;
Gaudin, Anne-Francoise ;
Vainchtock, Alexandre ;
Durand-Zaleski, Isabelle .
JOURNAL OF STROKE & CEREBROVASCULAR DISEASES, 2014, 23 (02) :E73-E83